Al is driven by a profound curiosity about the inner workings of natural systems and how things work. Leveraging this understanding, Al’s approach is to treat each business as a system.  

​

With over 20 years of experience as a CEO and Investor, he has amassed a wealth of knowledge in scaling diverse enterprises. His expertise blends operational acumen with astute investment strategies.

​​

Before founding WaveFx™, Al co-led ClinEdge for 11 years, where he pioneered innovative solutions in the clinical research landscape. His tenure underscored the challenges and rewards of cultivating a global business ecosystem, marked by visionary leadership and meticulous architectural planning. Under his stewardship, ClinEdge evolved into a multinational enterprise spanning 40 countries before its acquisition by Elligo Health Research in 2021. Al continues to be actively involved as an investor and strategic partner in the company.

​

Al's foundational philosophy revolves around building systems that prioritize organic growth, comprehensive data assimilation, streamlined workflows, and a harmonious balance between decentralization and centralization. He emphasizes the interconnectedness of information and a deep understanding of systemic dynamics, channeling energy toward positive outcomes.

​

Beyond the boardroom, Al thrives on embracing physical and intellectual challenges, with a diverse range of interests spanning biology, physics, chemistry, spirituality, and history. As a proud New Englander, he cherishes moments spent with his wife and two daughters, exploring the serene landscapes of Buzzards Bay and the White Mountains of New Hampshire.

 

The Wave Function

Currently at the helm of Wave Function™™™ (WaveFx), Al collaborates with early-stage, purpose-driven ventures across various sectors including healthcare, hospitality, energy, personal wellness, manufacturing, blockchain, and technology. He is deeply committed to supporting companies that redefine conventional business paradigms, striving to generate tangible value for both communities and individuals. Noteworthy ventures in his portfolio include ClinX, ClinEdge, BTC Network, Realtime Clinical Trial Management Systems, Elligo Health Research, and Lazarus AI.